GSE106336
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance
The goal of this study was to determine the transcriptional changes in pancreatic cancer cells after treatment with gemcitabine. Overall design: HPAFII cells were treated with PBS or Gemcitabine for 72 hours. RNA was harvested from 3 independent, experimental replicates per treatment group.